OLS Omni Life Science
Private Company
Total funding raised: $1.8M
Overview
OLS Omni Life Science is a specialized tools and consumables provider for the cell biology and therapy research market. The company operates as a distributor and integrator of best-in-class instrumentation from various manufacturers, combined with its own application expertise and services, to offer complete workflow solutions. Its focus areas include stem cell research, oncology, immunology, and 3D model development, positioning it as a key enabler for next-generation biomedical research. As a private company, it generates revenue through product sales, service contracts, and tailored support packages.
Technology Platform
Integrated portfolio of third-party and supported instruments for complete cell research workflows, including cell counting (CASY), 3D culture/bioreactors (CERO), real-time cell analysis (xCELLigence), flow cytometry (NovoCyte), high-content imaging (WiScan Hermes), and single-cell isolation (CellRaft AIR).
Funding History
1Opportunities
Risk Factors
Competitive Landscape
OLS competes in the fragmented life science tools distribution and support market. Primary competitors include large global players like Thermo Fisher Scientific, Danaher (through its subsidiaries), and Sartorius, which offer broad portfolios and direct sales, as well as other regional specialty distributors and the direct sales forces of the instrument manufacturers it represents.